Researchers discover why new melanoma drug stops working

November 24, 2011 in Cancer

(Medical Xpress) -- Research led by investigators at Memorial Sloan-Kettering Cancer Center has identified a previously unknown mechanism of resistance to the newly approved melanoma drug, vemurafenib, an oral targeted therapy used to treat advanced melanoma whose tumors contain a mutation in a gene called BRAF. The results of the study are published in the November 23rd advanced online edition of the journal Nature.

Vemurafenib, a targeted cancer drug, has been heralded as one of the biggest advances in the treatment of metastatic in the past 25 years and is now the standard of care for patients with the disease. Until now, however, researchers didn’t understand how patients were becoming resistant to the targeted therapy, which was approved by the FDA in August, 2011.

As with most targeted inhibitors, resistance to the drug invariably develops, and pinpointing why this occurs is critical to developing future treatments or combinations of treatments that can overcome the resistance and further extend the lives of patients faced with this deadly disease.

The research was led by senior author David Solit, an Associate Attending Physician on the Genitourinary Oncology Service and member of the Human Oncology and Pathogenesis Program, and included the work of colleagues at Memorial Sloan-Kettering. For the first time, the team isolated a variant splice form of BRAF that causes to the drug in the lab. Along with physician-scientists at Memorial Sloan-Kettering and collaborating institutions across the country, this variant was proven clinically relevant in patients.

Memorial Sloan-Kettering has been integrally involved in both the pre-clinical and clinical studies of vemurafenib. Investigators at Memorial Sloan-Kettering were the first to define the basis for the drug’s selectivity for tumors that express mutant BRAF. The first-in-man and the pivotal phase III clinical trials that led to the FDA approval were also led by principal investigator Paul Chapman of Memorial Sloan-Kettering.

Provided by Memorial Sloan-Kettering Cancer Center

not rated yet  

Rank not rated yet
Relevant PhysicsForums posts
  • Potential Breakthrough in Seizure Control
    created10 hours ago
  • Popping/Cracked sternum.
    created14 hours ago
  • Which Mental Illness Encompasses This Problem?
    created15 hours ago
  • A question about drug tolerance
    createdMay 23, 2012
  • Poor nutrition leading to overeating?
    createdMay 23, 2012
  • Math and dyslexia?
    createdMay 21, 2012
  • More from Physics Forums - Medical Sciences

More news stories

Skp2 activates cancer-promoting, glucose-processing Akt

HER2 and its epidermal growth factor receptor cousins mobilize a specialized protein to activate a major player in cancer development and sugar metabolism, scientists report in the May 25 issue of Cell.

Cancer created 22 hours ago | popularity not rated yet | comments 0 | with audio podcast

Pancreatectomy OK without downstaging from therapy

(HealthDay) -- Pancreatectomy improves median survival in pancreatic cancer patients even when presurgical neoadjuvant therapy does not lead to radiographic downstaging of tumors, according to a study published ...

Cancer created May 25, 2012 | popularity not rated yet | comments 0

Common therapies for basal cell carcinoma offer similar survival

(HealthDay) -- For patients with superficial basal cell carcinoma (sBCC), treatment with imiquimod or photodynamic therapy (PDT) results in similar long-term tumor-free survival, according to a review published ...

Cancer created May 25, 2012 | popularity not rated yet | comments 0

Cancer may require simpler genetic mutations than previously thought

Chromosomal deletions in DNA often involve just one of two gene copies inherited from either parent. But scientists haven't known how a deletion in one gene from one parent, called a "hemizygous" deletion, can contribute ...

Cancer created May 25, 2012 | popularity not rated yet | comments 0 | with audio podcast

New prostate cancer screening guidelines face a tough sell, study suggests

(Medical Xpress) -- Recent recommendations from the U.S. Preventive Services Task Force (USPSTF) advising elimination of routine prostate-specific antigen (PSA) screening for prostate cancer in healthy men are likely to encounter ...

Cancer created May 25, 2012 | popularity not rated yet | comments 1


Travel to high altitudes tied to Crohn's, colitis flare-ups

(HealthDay) -- People with inflammatory bowel disease, which includes Crohn's disease and colitis, may be at increased risk for flare-ups when they fly or travel to high altitudes for skiing or mountain climbing, ...

Family history of Alzheimer's affects functional connectivity

(HealthDay) -- Cognitively normal individuals with a family history of late-onset Alzheimer's disease (AD) may display lower resting state functional connectivity in the default mode network (DMN) of the brain, ...

Transvaginal mesh op restores pelvic organ prolapse at price

(HealthDay) -- Transvaginal mesh (TVM) procedures are effective for anatomical restoration of pelvic organ prolapse (POP), but patients report a worsening of sexual function following surgery, according to ...

Tongue analysis software uses ancient Chinese medicine to warn of disease

For 5,000 years, the Chinese have used a system of medicine based on the flow and balance of positive and negative energies in the body. In this system, the appearance of the tongue is one of the measures used to classify ...

Early physical therapist treatment associated with reduced risk of healthcare utilization and reduced overall healthcare

A new study published in Spine shows that early treatment by a physical therapist for low back pain (LBP), as compared to delayed treatment, was associated with reduced risk of subsequent healthcare utilization and lower ...

Flesh-Eating bacteria no cause for panic, experts say

(HealthDay) -- Despite scary headlines by the score, most people don't have to fear that they'll be the next victim of the so-called flesh-eating bacteria disease, experts say.